UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 943

Sortiert nach

Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508

Life sciences (1973), 2023-04, Vol.318, p.121475-121475, Article 121475

2023

Volltextzugriff (PDF)

Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation

International journal of radiation oncology, biology, physics, 2007-02, Vol.67 (2), p.327-333

2007

Volltextzugriff (PDF)

Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

JAMA oncology, 2019-02, Vol.5 (2), p.213

2019

Volltextzugriff (PDF)

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

JAMA : the journal of the American Medical Association, 2009-08, Vol.302 (8), p.866

2009

Volltextzugriff (PDF)

Definition and Validation of “Favorable High-Risk Prostate Cancer”: Implications for Personalizing Treatment of Radiation-Managed Patients

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (4), p.828-835

2015

Volltextzugriff (PDF)

Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death

European urology, 2016-06, Vol.69 (6), p.976-979

2016

Volltextzugriff (PDF)

G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis

Acta diabetologica, 2016-04, Vol.53 (2), p.177-188

2016

Volltextzugriff (PDF)

Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion

Peptides (New York, N.Y. : 1980), 2018-02, Vol.100, p.165-172

2018

Volltextzugriff (PDF)

Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

Diabetologia, 2016-12, Vol.59 (12), p.2674-2685

2016

Volltextzugriff (PDF)

Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy

Brachytherapy, 2021-01, Vol.20 (1), p.38-43

2021

Volltextzugriff (PDF)

Development of novel ligands for peptide GPCRs

Current opinion in pharmacology, 2016-12, Vol.31, p.57-62

2016

Volltextzugriff (PDF)

Constitutive Model of Soft Tissue: From Nanoscale Collagen to Tissue Continuum

Annals of biomedical engineering, 2009-06, Vol.37 (6), p.1117-1130

2009

Volltextzugriff (PDF)

Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

BJU international, 2015-09, Vol.116 (3), p.358-365

2015

Volltextzugriff (PDF)

Establishing High-Quality Prostate Brachytherapy Using a Phantom Simulator Training Program

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (3), p.579-586

2014

Volltextzugriff (PDF)

External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis

International journal of radiation oncology, biology, physics, 2023-03, Vol.115 (3), p.645-653

2023

Volltextzugriff (PDF)

The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy

Urologic oncology, 2022-01, Vol.40 (1), p.6.e21-6.e27

2022

Volltextzugriff (PDF)

Race and mortality risk after radiation therapy in men treated with or without androgen‐suppression therapy for favorable‐risk prostate cancer

Cancer, 2016-12, Vol.122 (23), p.3608-3614

2016

Volltextzugriff (PDF)

Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone

International journal of radiation oncology, biology, physics, 2016-07, Vol.95 (4), p.1158-1167

2016

Volltextzugriff (PDF)

Seizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changes

Epilepsy & behavior, 2015-07, Vol.48, p.70-74

2015

Volltextzugriff (PDF)

Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease

Journal of clinical oncology, 2009-08, Vol.27 (24), p.3923-3928

2009

Volltextzugriff (PDF)

Crack tip fields in a neo-Hookean sheet reinforced by nonlinear fibers

Journal of the mechanics and physics of solids, 2021-07, Vol.152, p.104406, Article 104406

2021

Volltextzugriff (PDF)

Long-term biochemical outcomes using cesium-131 in prostate brachytherapy

Brachytherapy, 2019-11, Vol.18 (6), p.800-805

2019

Volltextzugriff (PDF)

Current and Future Therapies for Pancreatic Ductal Adenocarcinoma

Cancers, 2022-05, Vol.14 (10), p.2417

2022

Volltextzugriff (PDF)

Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer

JAMA oncology, 2015-06, Vol.1 (3), p.334

2015

Volltextzugriff (PDF)

1 – 25 von 943

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(765)
Mit Volltextzugriff
(837)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(527)
Life Sciences & Biomedicine
(428)
Humans
(320)
Male
(171)
Female
(128)
Biological And Medical Sciences
(87)
Middle Aged
(87)
Adult
(86)
Aged
(80)
Medical Sciences
(70)
Oncology
(69)
Physical Sciences
(58)
Surgery
(58)
Technology
(58)
Animals
(57)
Treatment Outcome
(48)
Adolescent
(45)
Radiology, Nuclear Medicine & Medical Imaging
(44)
Risk Factors
(44)
Prostatic Neoplasms - Radiotherapy
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508

Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation

Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

Definition and Validation of “Favorable High-Risk Prostate Cancer”: Implications for Personalizing Treatment of Radiation-Managed Patients

Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death

G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis

Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion

Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy

Development of novel ligands for peptide GPCRs

Constitutive Model of Soft Tissue: From Nanoscale Collagen to Tissue Continuum

Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

Establishing High-Quality Prostate Brachytherapy Using a Phantom Simulator Training Program

External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis

The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy

Race and mortality risk after radiation therapy in men treated with or without androgen‐suppression therapy for favorable‐risk prostate cancer

Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone

Seizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changes

Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease

Crack tip fields in a neo-Hookean sheet reinforced by nonlinear fibers

Long-term biochemical outcomes using cesium-131 in prostate brachytherapy

Current and Future Therapies for Pancreatic Ductal Adenocarcinoma

Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer

Suchergebnisse filtern